Critical Survey: Bionik Laboratories (BNKL) & Sientra (SIEN)

Share on StockTwits

Bionik Laboratories (OTCMKTS:BNKL) and Sientra (NASDAQ:SIEN) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, valuation, analyst recommendations, institutional ownership, earnings, profitability and dividends.

Earnings & Valuation

This table compares Bionik Laboratories and Sientra’s top-line revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Bionik Laboratories $990,000.00 9.45 -$14.62 million N/A N/A
Sientra $68.13 million 2.90 -$82.63 million ($3.25) -2.08

Bionik Laboratories has higher earnings, but lower revenue than Sientra.

Profitability

This table compares Bionik Laboratories and Sientra’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Bionik Laboratories -556.03% -64.03% -52.27%
Sientra -126.32% -119.59% -50.38%

Institutional & Insider Ownership

96.5% of Sientra shares are owned by institutional investors. 45.9% of Bionik Laboratories shares are owned by insiders. Comparatively, 31.0% of Sientra shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Analyst Ratings

This is a summary of recent recommendations for Bionik Laboratories and Sientra, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Bionik Laboratories 0 0 0 0 N/A
Sientra 0 2 6 0 2.75

Sientra has a consensus price target of $21.00, indicating a potential upside of 210.65%. Given Sientra’s higher probable upside, analysts clearly believe Sientra is more favorable than Bionik Laboratories.

Risk and Volatility

Bionik Laboratories has a beta of -0.83, indicating that its stock price is 183% less volatile than the S&P 500. Comparatively, Sientra has a beta of -0.1, indicating that its stock price is 110% less volatile than the S&P 500.

Summary

Sientra beats Bionik Laboratories on 7 of the 11 factors compared between the two stocks.

About Bionik Laboratories

Bionik Laboratories Corp., a robotics company, focuses on providing rehabilitation and mobility solutions to individuals with neurological and mobility challenges from hospital to home. The company specializes in designing, developing, and commercializing physical rehabilitation technologies, prosthetics, and assisted robotic products. It offers InMotion Systems, which include the InMotion ARM that allows clinicians to deliver sensor motor therapy to the shoulder and elbow to develop new neural pathways; InMotion ARM/HAND, an add-on module to be used with the InMotion ARM; and InMotion WRIST, a rehabilitation device that enables clinicians to deliver optimum intensive sensor motor wrist and forearm therapy to patients with neurological conditions. The company is also developing InMotion HOME, an upper extremity product that allows patients to extend their therapy for as long as needed while rehabilitating at home; and ARKE, a robotic lower body exoskeleton designed for wheelchair bound individuals suffering from spinal cord injuries, stroke, and other mobility disabilities. Bionik Laboratories Corp. was founded in 2010 and is headquartered in Toronto, Canada.

About Sientra

Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products to plastic surgeons in the United States. It operates through two segments, Breast Products and miraDry. The company offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. It also provides body contouring products; facial and nasal implants; saline filled breast implant sizers; and miraDry System, a non-surgical device for the permanent reduction of underarm sweat, odor, and hair of all colors. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.

Receive News & Ratings for Bionik Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bionik Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Critical Survey: Bionik Laboratories  & Sientra
Critical Survey: Bionik Laboratories & Sientra
JPMorgan Multi-Asset Trust PLC  Insider Laurence Magnus Purchases 50,000 Shares
JPMorgan Multi-Asset Trust PLC Insider Laurence Magnus Purchases 50,000 Shares
Heritage Financial  Downgraded by Zacks Investment Research to Sell
Heritage Financial Downgraded by Zacks Investment Research to Sell
Credit Suisse Group Analysts Give Volkswagen  a €201.00 Price Target
Credit Suisse Group Analysts Give Volkswagen a €201.00 Price Target
Heritage Financial  Downgraded by Zacks Investment Research to Sell
Heritage Financial Downgraded by Zacks Investment Research to Sell
Amneal Pharmaceuticals  Trading 10.5% Higher
Amneal Pharmaceuticals Trading 10.5% Higher


© 2006-2019 Ticker Report